[Epidemiology of allergic respiratory disorders in infants]

M Herr1, L Nikasinovic, B Clarisse

  • 1Laboratoire Santé Publique et Environnement, EA 4064-Université Paris Descartes, Faculté des Sciences Pharmaceutiques et Biologiques, Paris, France.

Insights

Prevalence of allergic respiratory disorders in children under three varies significantly due to differing definitions. Improved diagnostic criteria are needed for accurate infant allergy assessment and care.

Area of Science:

  • Pediatric Allergy and Immunology
  • Respiratory Medicine
  • Epidemiology

Context:

  • Infancy is a critical period for immune system development and the onset of allergic diseases.
  • Existing studies on allergic respiratory disorders in young children lack standardized definitions for asthma and allergic rhinitis.
  • Wheezing occurs in one-third of children under three with lower respiratory infections, but only 7% wheeze independently.

Purpose:

  • To describe the prevalence of allergic respiratory disorders in children under three years of age within the general population.
  • To highlight the challenges posed by the lack of shared definitions in epidemiological studies of infant allergic respiratory conditions.

Summary:

  • Doctor-diagnosed asthma affects 5% of children under two; asthma-like cough and bronchial obstruction symptoms are reported in 15% and 9% respectively.
  • The prevalence of allergic rhinitis in two-year-olds ranges from 1% to 30%, depending heavily on the definition employed.
  • Current definitions are evolving to include family history, personal allergy history, medication use, and biological markers of atopy.

Impact:

  • Refined definitions of infant allergic respiratory disorders are crucial for advancing epidemiological research.
  • Improved diagnostic criteria will facilitate more accurate risk identification and early management strategies for infants.
  • Standardized definitions will enhance the reliability and comparability of future studies on pediatric respiratory allergies.
Abstract

Related Concept Videos

Asthma I: Introduction01:28

Asthma I: Introduction

Asthma is a chronic inflammatory disorder of the airways characterized by variable airflow obstruction and heightened bronchial responsiveness to a wide range of triggers. The underlying inflammation leads to airway swelling, mucus hypersecretion, and smooth muscle constriction, all of which narrow the airway lumen and impede airflow. Clinically, asthma presents with recurrent episodes of wheezing, shortness of breath, chest tightness, and coughing, symptoms that typically vary in intensity and...
Asthma-I: Introduction01:29

Asthma-I: Introduction

Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
Common Respiratory Disorders01:31

Common Respiratory Disorders

Respiratory disorders, a prevalent health concern globally, are generally divided into two primary categories: upper and lower respiratory tract disorders. The categorization is based on the area of the respiratory system they affect.
Upper respiratory disorders impact the airways above the vocal cords, encompassing areas like the nose, sinuses, and throat. Various conditions fall under this category, including the common cold and allergic rhinitis. These disorders can stem from several causes,...
Respiratory Syncytial Virus Disease01:29

Respiratory Syncytial Virus Disease

Human respiratory syncytial virus (RSV) is a widespread pathogen that primarily targets infants and young children but also poses a serious health risk to elderly and immunocompromised individuals. Belonging to the Pneumoviridae family, RSV is a negative-sense, single-stranded RNA virus within the Pneumovirus genus. Its global health burden is significant, with millions of cases annually resulting in hospitalizations and mortality, particularly in resource-limited settings. Although most...
Drugs Used in Lower Respiratory Disorders: Overview01:17

Drugs Used in Lower Respiratory Disorders: Overview

Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...